Catalyst Funds Management Pty LTD Merus N.V. Transaction History
Catalyst Funds Management Pty LTD
- $455 Billion
- Q3 2024
A detailed history of Catalyst Funds Management Pty LTD transactions in Merus N.V. stock. As of the latest transaction made, Catalyst Funds Management Pty LTD holds 800 shares of MRUS stock, worth $40,744. This represents 0.01% of its overall portfolio holdings.
Number of Shares
800Holding current value
$40,744% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding MRUS
# of Institutions
197Shares Held
62MCall Options Held
124KPut Options Held
208K-
Rtw Investments, LP New York, NY4.17MShares$212 Million3.32% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY3.41MShares$174 Million3.17% of portfolio
-
Commodore Capital LP New York, NY3.35MShares$171 Million14.22% of portfolio
-
Wellington Management Group LLP Boston, MA2.89MShares$147 Million0.03% of portfolio
-
Samlyn Capital, LLC New York, NY2.61MShares$133 Million2.1% of portfolio
About Merus N.V.
- Ticker MRUS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 45,878,200
- Market Cap $2.34B
- Description
- Merus N.V., a clinical-stage immuno-oncology company, engages in the discovery and development of bispecific antibody therapeutics in the Netherlands. Its bispecific antibody candidate pipeline includes Zenocutuzumab (MCLA-128), which is in a phase 2 clinical trials for the treatment of patients with metastatic breast cancer, as well as in Phase...